-
Developing therapeutics for ovarian cancer using ovarian cancer organoids
Study
JGAS000764
-
Gene expression profile of mesothelial-derived carcinoma-associated fibroblasts
Study
EGAS00001003747
-
Early detection of ovarian cancer using cell-free DNA fragmentomes and protein biomarkers
Study
EGAS50000000484
-
Identification of genetic mutations characteristic for recurrence of serous ovarian cancer.
Study
JGAS000104
-
Genetic Epidemiology of Ovarian Cancer Histotypes
Study
phs003140
-
Sequencing data of tumor tissue obtained from GANNET53 study patients
Study
EGAS50000000935
-
Automated system for scoring hematoxylin and eosin-stained ovarian cancer sections by identifying single cells uncovered that stromal cell ratio is a significant predictor for overall survival and progression-free survival.
Study
EGAS00001001694
-
SCANDARE ovarian
Study
EGAS50000001161
-
Adaptive Therapy Exploits Fitness Deficits in Chemotherapy-Resistant Ovarian Cancer to Achieve Long-Term Tumor Control Open Access
Study
EGAS50000001142
-
Improved T Cell Immunity Following Neoadjuvant Chemotherapy in Ovarian Cancer
Study
phs002862
-
Circulating tumour DNA (ctDNA) data of High Grade Serous Ovarian Cancer Patients
Study
EGAS50000000674
-
RESOLVE_trial_targeted_sequencing_data
Study
EGAS50000001202
-
Copy-Number Analysis of Understudied Black Women Ovarian Cancers
Study
phs002313
-
Exceptional Outcomes in a Phase Ib Study Combining PARP and MEK Inhibition, With or Without Anti-PD-L1, for BRCA-Wildtype Platinum-Sensitive Recurrent Ovarian Cancer
Study
EGAS00001007496
-
Copy-number signatures and mutational processes in ovarian carcinoma
Study
EGAS00001002557
-
Metabolomic and transcriptomic analyses identify metabolic alterations and immune suppression in ovarian cancer
Study
JGAS000831
-
Whole Genome Sequencing Data of High Grade Serous Ovarian Cancer
Study
EGAS00001006775
-
Integrated Genomic, Epigenetic, and Expression Analyses of Ovarian Cancer Cell Lines
Study
EGAS00001002998
-
cfDNA dataset from the urine supernatant of ovarian cancer patients and healthy controls
Study
EGAS00001007238
-
Genomic landscapes of endometrioid and mucinous ovarian cancers and morphologically similar tumor types
Study
EGAS50000000523
-
OncoArray: Follow-up of Ovarian Cancer Genetic Association and Interaction Studies (FOCI)
Study
phs001882
-
Premalignant SOX2 overexpression in the fallopian tubes of ovarian cancer patients: Discovery and validation studies
Study
EGAS00001001909
-
High Grade Serous Ovarian Carcinomas Originate in the Fallopian Tube
Study
EGAS00001002589
-
Phase I Study of the Oral PI3kinase Inhibitor BKM120 or BYL719 and the Oral PARP Inhibitor Olaparib in Patients with Recurrent Triple Negative Breast Cancer or High Grade Serous Ovarian Cancer
Study
phs003019
-
Nucleosome footprinting in plasma cell-free DNA for diagnosis of ovarian cancer
Study
EGAS00001005361